Demcizumab (Anti-DLL4)

製品コード：A2520        

印刷

Demcizumab (Anti-DLL4) is a monoclonal antibody taregting DLL4. Demcizumab is a potent inhibitor of the Notch pathway. Demcizumab alone or in combination with chemotherapy is effective in various cancer models. MW: 145.5 KD.

製品説明

CAS No. 1243262-17-0
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Isotype Human IgG2SA
Source CHO
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Shipping Shipped under low temperature conditions

人間や獣医の診断であるか治療的な使用のためにでない。